Your browser doesn't support javascript.
loading
Generation of human induced pluripotent stem cell line MHHi029-A from a male Fabry disease patient carrying c.959A > T mutation.
Jahn, Christopher; Juchem, Malte; Sonnenschein, Kristina; Gietz, Anika; Buchegger, Theresa; Lachmann, Nico; Göhring, Gudrun; Behrens, Yvonne Lisa; Bär, Christian; Thum, Thomas; Hoepfner, Jeannine.
Affiliation
  • Jahn C; Institute of Molecular and Translational Therapeutic Strategies, Hannover Medical School, Hannover, Germany.
  • Juchem M; Institute of Molecular and Translational Therapeutic Strategies, Hannover Medical School, Hannover, Germany.
  • Sonnenschein K; Institute of Molecular and Translational Therapeutic Strategies, Hannover Medical School, Hannover, Germany; Department of Cardiology und Angiology, Hannover Medical School, Hannover, Germany.
  • Gietz A; Institute of Molecular and Translational Therapeutic Strategies, Hannover Medical School, Hannover, Germany.
  • Buchegger T; Department of Pediatric Pneumology, Allergology and Neonatology, Hannover Medical School, Hannover, Germany.
  • Lachmann N; Department of Pediatric Pneumology, Allergology and Neonatology, Hannover Medical School, Hannover, Germany; Fraunhofer Institute for Toxicology and Experimental Medicine (ITEM), Hannover, Germany; Center of Translational Regenerative Medicine, Hannover Medical School, Hannover, Germany.
  • Göhring G; Department of Human Genetics, Hannover Medical School, Hannover, Germany.
  • Behrens YL; Department of Human Genetics, Hannover Medical School, Hannover, Germany.
  • Bär C; Institute of Molecular and Translational Therapeutic Strategies, Hannover Medical School, Hannover, Germany; Fraunhofer Institute for Toxicology and Experimental Medicine (ITEM), Hannover, Germany; Center of Translational Regenerative Medicine, Hannover Medical School, Hannover, Germany.
  • Thum T; Institute of Molecular and Translational Therapeutic Strategies, Hannover Medical School, Hannover, Germany; Center of Translational Regenerative Medicine, Hannover Medical School, Hannover, Germany.
  • Hoepfner J; Institute of Molecular and Translational Therapeutic Strategies, Hannover Medical School, Hannover, Germany. Electronic address: hoepfner.jeannine@mh-hannover.de.
Stem Cell Res ; 77: 103404, 2024 Jun.
Article in En | MEDLINE | ID: mdl-38552356
ABSTRACT
Fabry disease (FD) is a rare and inherited monogenetic disease caused by mutations in the X-chromosomal alpha-galactosidase A gene GLA concomitant with accumulation of its substrate globotriaosylceramide (Gb3) and multi-organ symptoms. We derived an induced pluripotent stem cell line, MHHi029-A, from a male FD patient carrying a c.959A > T missense mutation in the GLA gene. The hiPSCs show a normal karyotype, expression of pluripotency markers and trilineage differentiation capacity. Importantly, they present the patient-specific mutation in the GLA gene and are therefore a valuable resource for investigating the FD mechanism and identifying novel therapies.
Subject(s)

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Fabry Disease / Alpha-Galactosidase / Induced Pluripotent Stem Cells Limits: Humans / Male Language: En Journal: Stem Cell Res Year: 2024 Document type: Article Affiliation country: Germany Country of publication: United kingdom

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Fabry Disease / Alpha-Galactosidase / Induced Pluripotent Stem Cells Limits: Humans / Male Language: En Journal: Stem Cell Res Year: 2024 Document type: Article Affiliation country: Germany Country of publication: United kingdom